Beam Therapeutics Inc (BEAM)
23.58
-0.91
(-3.72%)
USD |
NASDAQ |
Nov 21, 16:00
23.60
+0.02
(+0.08%)
Pre-Market: 08:08
Beam Therapeutics Profit Margin (Quarterly): -677.5% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -677.5% |
| June 30, 2024 | -773.5% |
| March 31, 2024 | -1.33K% |
| December 31, 2023 | 45.16% |
| September 30, 2023 | -558.9% |
| June 30, 2023 | -411.5% |
| March 31, 2023 | -398.5% |
| December 31, 2022 | -191.4% |
| September 30, 2022 | -693.6% |
| June 30, 2022 | -432.1% |
| March 31, 2022 | -820.8% |
| Date | Value |
|---|---|
| December 31, 2021 | -126.7% |
| September 30, 2021 | -3.69K% |
| June 30, 2021 | -1.27M% |
| March 31, 2021 | -3.36M% |
| December 31, 2020 | -1.59M% |
| September 30, 2020 | -574.2K% |
| June 30, 2020 | -570.3K% |
| March 31, 2020 | -507.6K% |
| December 31, 2019 | -464.2K% |
| September 30, 2019 | -316.8K% |
| June 30, 2019 | -297.7K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.36M%
Minimum
Mar 2021
45.16%
Maximum
Dec 2023
-417.4K%
Average
-797.2%
Median
Profit Margin (Quarterly) Benchmarks
| Bruker Corp | 4.73% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 10.05% |
| Xtant Medical Holdings Inc | -17.98% |
| Myomo Inc | -10.50% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -16.62% |
| Return on Assets | -10.97% |
| Return on Invested Capital | -16.62% |
| Operating Margin (Quarterly) | -746.4% |
| Return on Net Operating Assets | -62.43% |